CMA Sees Fine Over Nortriptyline Upheld In UK
Lexon’s Appeal Dismissed By Competition Tribunal
Executive Summary
The UK’s Competition and Markets Authority has welcomed a ruling upholding its finding that Lexon broke competition law in relation to nortriptyline, along with a connected £1.2m fine.